287 related articles for article (PubMed ID: 22712271)
1. [Nanostructured liposomal systems as transport agents for anticancer drugs].
Baryshnikov AIu
Vestn Ross Akad Med Nauk; 2012; (3):23-31. PubMed ID: 22712271
[TBL] [Abstract][Full Text] [Related]
2. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor.
Abu Lila AS; Doi Y; Nakamura K; Ishida T; Kiwada H
J Control Release; 2010 Mar; 142(2):167-73. PubMed ID: 19861140
[TBL] [Abstract][Full Text] [Related]
3. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
Rudokas M; Najlah M; Alhnan MA; Elhissi A
Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
Abu Lila AS; Ishida T; Kiwada H
Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
[TBL] [Abstract][Full Text] [Related]
6. Targeting anticancer drugs to tumor vasculature using cationic liposomes.
Abu Lila AS; Ishida T; Kiwada H
Pharm Res; 2010 Jul; 27(7):1171-83. PubMed ID: 20333455
[TBL] [Abstract][Full Text] [Related]
7. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
8. Immunoliposomes for cancer therapy.
Kontermann RE
Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
[TBL] [Abstract][Full Text] [Related]
9. Colloidal systems for tumor targeting.
Storm G; Crommelin DJ
Hybridoma; 1997 Feb; 16(1):119-25. PubMed ID: 9085138
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of liposomal drug carrier systems in cancer chemotherapy.
Gabizon A
J Liposome Res; 2003 Feb; 13(1):17-20. PubMed ID: 12725722
[No Abstract] [Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting using liposomal antineoplastic drugs.
Huwyler J; Drewe J; Krähenbuhl S
Int J Nanomedicine; 2008; 3(1):21-9. PubMed ID: 18488413
[TBL] [Abstract][Full Text] [Related]
13. A liposomal delivery vehicle for the anticancer agent gossypol.
Zhai G; Wu J; Zhao X; Yu B; Li H; Lu Y; Ye W; Lin YC; Lee RJ
Anticancer Res; 2008; 28(5A):2801-5. PubMed ID: 19035313
[TBL] [Abstract][Full Text] [Related]
14. Cationic liposomes as in vivo delivery vehicles.
Smyth Templeton N
Curr Med Chem; 2003 Jul; 10(14):1279-87. PubMed ID: 12678799
[TBL] [Abstract][Full Text] [Related]
15. Sterically stabilized liposomes as a potent carrier for shikonin.
Kontogiannopoulos KN; Tsermentseli SK; Assimopoulou AN; Papageorgiou VP
J Liposome Res; 2014 Sep; 24(3):230-40. PubMed ID: 24597496
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric cationic liposomes designed for heat-activated association with cells.
Jing Y; Danielsson A; Trefná HD; Persson M; Svedhem S
Colloids Surf B Biointerfaces; 2017 Mar; 151():112-118. PubMed ID: 27987456
[TBL] [Abstract][Full Text] [Related]
17. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives.
Papachristos A; Pippa N; Ioannidis K; Sivolapenko G; Demetzos C
J Liposome Res; 2015; 25(2):166-73. PubMed ID: 25148295
[TBL] [Abstract][Full Text] [Related]
18. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy.
Gardikis K; Hatziantoniou S; Bucos M; Fessas D; Signorelli M; Felekis T; Zervou M; Screttas CG; Steele BR; Ionov M; Micha-Screttas M; Klajnert B; Bryszewska M; Demetzos C
J Pharm Sci; 2010 Aug; 99(8):3561-71. PubMed ID: 20564386
[TBL] [Abstract][Full Text] [Related]
19. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
Shi C; Cao H; He W; Gao F; Liu Y; Yin L
Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
[TBL] [Abstract][Full Text] [Related]
20. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
